Holen Sie sich die Stockscreener-App
149.86
1.47%
-2.23
Handel nachbörslich:
150.84
0.98
+0.65%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products - TradingView
Retirement Systems of Alabama Sells 7,647 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Illumina price driven lower by pivotal resistanceForecast today26-01-2026 - Economies.com
Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat
iA Global Asset Management Inc. Purchases New Position in Illumina, Inc. $ILMN - MarketBeat
9,062 Shares in Illumina, Inc. $ILMN Purchased by Rakuten Investment Management Inc. - MarketBeat
Illumina Inc. (ILMN) shares see target boost as analysts see potential 2026 upside - MSN
Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance? - Yahoo Finance
Customer Engagement Center - Illumina
Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Whole Genome and Exome Sequencing: Global Market Review 2021-2025 and Growth Outlook 2026-2031 Featuring Illumina, Thermo Fisher Scientific, BGI Genomics and Other Leading Players - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 - GlobeNewswire
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance
United States Agrigenomics Market | CAGR 8% | North America Leads - openPR.com
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Illumina stock hits 52-week high at 151.35 USD By Investing.com - Investing.com Australia
Dubai Health embraces genomics to advance care and research - Illumina
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Sahm
Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest - Yahoo Finance
The Truth About Illumina Inc.: Is This Genomics Giant Still Worth Your Money? - AD HOC NEWS
Illumina (NASDAQ:ILMN) Sets New 52-Week HighHere's What Happened - MarketBeat
Illumina and Powell Gilbert in love with Lisbon - JUVE Patent
Illumina stock hits 52-week high at 151.35 USD - Investing.com
11,407 Shares in Illumina, Inc. $ILMN Acquired by Inscription Capital LLC - MarketBeat
North America Bioinformatics Market Size, Share, Trends, - openPR.com
Illumina Secures CMS Reimbursement for TruSight Oncology Test at $2,989.55 - Intellectia AI
Illumina Gets Medicare Boost for Cancer Test, Shares Climb - Benzinga
Evaluating next‑generation cloud compute for large‑scale genomic processing - Amazon Web Services (AWS)
Illumina secures CMS reimbursement for TruSight™ Oncology Compre - GuruFocus
Illumina secures CMS reimbursement for cancer genomic test at $2,989 - Investing.com
Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq
Illumina secures CMS reimbursement for cancer genomic test at $2,989 By Investing.com - Investing.com Nigeria
Press Release - Illumina
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire
Stifel raises Illumina stock price target to $155 on growth outlook - Investing.com
GRAIL Inc.Illumina's Divested Holy Grail (NASDAQ:GRAL) - Seeking Alpha
Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Finviz
The Technical Signals Behind (ILMN) That Institutions Follow - Stock Traders Daily
Illumina: What Is Next In This Sequence? (NASDAQ:ILMN) - Seeking Alpha
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance
2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026] - 2 Minute Medicine
Is Now An Opportune Moment To Examine Illumina, Inc. (NASDAQ:ILMN)? - 富途资讯
Nordea Investment Management AB Buys 19,519 Shares of Illumina, Inc. $ILMN - MarketBeat
Oncology Research Solutions - Illumina
Stephens Investment Management Group LLC Boosts Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Acquired by ASR Vermogensbeheer N.V. - MarketBeat
Illumina, Inc.Common Stock (NQ: ILMN - FinancialContent
Genetic Disease Research Solutions - Illumina
Illumina partners with pharma giants to map disease biology at unprecedented scale - Mugglehead Magazine
2026: A turning point for precision health - Illumina
Illumina reports preliminary Q4 revenue of $1.15B - MSN
1.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):